Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-22

Clinical Trial Update: Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler [Phase 1]

View source ↗

Summary

A Phase 1 study comparing the absorption of budesonide/formoterol delivered by the Easyhaler versus the Turbuhaler in asthma, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide/Formoterol Easyhaler (budesonide/formoterol)
  • Symbicort Turbuhaler (budesonide/formoterol)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Asthma | Phase 1 | Status: COMPLETED